Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision
Recruiting · NCT02280889 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Children's Hospital, Zurich
View the official record on ClinicalTrials.gov →What this trial is about
Congenital melanocytic nevi (CMN) are a quite common congenital disorder. Over years, surgical excision was proposed to the patients because transformation into a malignant skin tumor (melanoma) was feared. Recent data proof that the risk for malignancy was overestimated. Nowadays still a lot of patients express their wish for surgical removal out of aesthetic reasons and psychological impacts. Many patients and families experience stigmatization because of the nevus. To proof a medical indication for surgical removal the investigators want to evaluate the quality of life and stigmatization before and after nevus surgery.
Who can take part
Inclusion criteria
- patients with a congenital melanocytic nevi of at least 2 cm2 that will be removed surgically
- age between 9 months and 16 years
Exclusion criteria
- mental retardation of the child
- insufficient knowledge of the German language of both parents
- severe comorbidities
- previous therapies done for the CMN (dermabrasion, surgery, laser)
Where it is running
1 location listed.
- University Children's Hospital Zurich, Division of Pediatric Plastic and reconstructive Surgery - Zurich, Switzerland